Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: A cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA)

BMC Nephrology

Volumn 9, Issue 1, 2008, Pages

  Keller, Christopher ^a,b   Katz, Ronit ^c   Cushman, Mary ^d   Fried, Linda F ^e   Shlipak, Michael ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF VERMONT   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 8; C REACTIVE PROTEIN; CREATININE; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; PROCOAGULANT; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; CYSTATIN; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ATHEROSCLEROSIS; CHINESE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ETHNIC DIFFERENCE; FEMALE; GLOMERULUS FILTRATION RATE; HISPANIC; HUMAN; KIDNEY FUNCTION; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NEPHRITIS; RACE DIFFERENCE; UNITED STATES; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; ETHNIC GROUP; ETHNOLOGY; INFLAMMATION; KIDNEY; KIDNEY DISEASE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; STATISTICS; THROMBOPHILIA;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; CREATININE; CROSS-SECTIONAL STUDIES; CYSTATINS; ETHNIC GROUPS; FACTOR VIII; FEMALE; FIBRINOGEN; GLOMERULAR FILTRATION RATE; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; THROMBOPHILIA; UNITED STATES;

EID: 51649092375     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-9-9     Document Type: Article

References (33)

1. Inflammatory markers and the risk of coronary heart disease in men and women. JK Pai T Pischon J Ma JE Manson SE Hankinson K Joshipura GC Curhan N Rifai CC Cannuscio MJ Stampfer, N Engl J Med 2004 351 25 2599 2610 15602020 10.1056/NEJMoa040967
2. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. PM Ridker CH Hennekens JE Buring N Rifai, N Engl J Med 2000 342 12 836 843 10733371 10.1056/NEJM200003233421202
3. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. PM Ridker N Rifai MJ Stampfer CH Hennekens, Circulation 2000 101 15 1767 1772 10769275
4. Elevated serum levels of C-reactive protein in hemodialysis patients. D Docci R Bilancioni A Buscaroli L Baldrati C Capponcini S Mengozzi F Turci C Feletti, Nephron 1990 56 4 364 367 2079993
5. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha. A Herbelin AT Nguyen J Zingraff P Urena B Descamps-Latscha, Kidney Int 1990 37 1 116 125 2299797 10.1038/ki.1990.16
6. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. J Zimmermann S Herrlinger A Pruy T Metzger C Wanner, Kidney Int 1999 55 2 648 658 9987089 10.1046/j.1523-1755.1999.00273.x
7. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. R Pecoits-Filho P Barany B Lindholm O Heimburger P Stenvinkel, Nephrol Dial Transplant 2002 17 9 1684 1688 12198224 10.1093/ndt/17.9.1684
8. The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. P Muntner LL Hamm JW Kusek J Chen PK Whelton J He, Ann Intern Med 2004 140 1 9 17 14706967
9. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. MG Shlipak LF Fried C Crump AJ Bleyer TA Manolio RP Tracy CD Furberg BM Psaty, Circulation 2003 107 1 87 92 12515748 10.1161/01.CIR.0000042700.48769.59
10. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. E Coll A Botey L Alvarez E Poch L Quinto A Saurina M Vera C Piera A Darnell, Am J Kidney Dis 2000 36 1 29 34 10873868 10.1053/ajkd.2000.8237
11. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. BA Perkins RG Nelson BE Ostrander KL Blouch AS Krolewski BD Myers JH Warram, J Am Soc Nephrol 2005 16 5 1404 1412 15788478 10.1681/ASN.2004100854
12. Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function. E Randers EJ Erlandsen OL Pedersen C Hasling H Danielsen, Clin Nephrol 2000 54 3 203 209 11020018
13. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). AS Levey KU Eckardt Y Tsukamoto A Levin J Coresh J Rossert D De Zeeuw TH Hostetter N Lameire G Eknoyan, Kidney Int 2005 67 6 2089 2100 15882252 10.1111/j.1523-1755.2005. 00365.x
14. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. AD Rule TS Larson EJ Bergstralh JM Slezak SJ Jacobsen FG Cosio, Ann Intern Med 2004 141 12 929 937 15611490
15. Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. CR Keller MC Odden LF Fried AB Newman S Angleman CA Green SR Cummings TB Harris MG Shlipak, Kidney Int 2007 71 3 239 244 17183246 10.1038/sj.ki.5002042
16. Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. D Singh MA Whooley JH Ix S Ali MG Shlipak, Nephrol Dial Transplant 2007 22 4 1087 1092 17210589 10.1093/ndt/gfl744
17. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. EJ Erlandsen E Randers JH Kristensen, Scand J Clin Lab Invest 1999 59 1 1 8 10206092 10.1080/00365519950185940
18. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. AS Levey J Coresh E Balk AT Kausz A Levin MW Steffes RJ Hogg RD Perrone J Lau G Eknoyan, Ann Intern Med 2003 139 2 137 147 12859163
19. Variation in the serum creatinine assay calibration: a practical application to glomerular filtration rate estimation. K Murthy LA Stevens PC Stark AS Levey, Kidney Int 2005 68 4 1884 1887 16164667 10.1111/j.1523-1755. 2005.00608.x
20. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. WT Friedewald RI Levy DS Fredrickson, Clin Chem 1972 18 6 499 502 4337382
21. Relationship between C-reactive protein levels and regional left ventricular function in asymptomatic individuals: the Multi-Ethnic Study of Atherosclerosis. BD Rosen M Cushman K Nasir DA Bluemke T Edvardsen V Fernandes S Lai RP Tracy JA Lima, J Am Coll Cardiol 2007 49 5 594 600 17276184 10.1016/j.jacc.2006.09.040
22. Serum cystatin C as a marker of the renal function. E Randers JH Kristensen EJ Erlandsen H Danielsen, Scand J Clin Lab Invest 1998 58 7 585 592 9890342 10.1080/00365519850186210
23. Cystatin C: a marker of renal function or something more? G Curhan, Clin Chem 2005 51 2 293 294 15681558 10.1373/clinchem.2004.044388
24. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. W Koenig D Twardella H Brenner D Rothenbacher, Clin Chem 2005 51 2 321 327 15563478 10.1373/clinchem.2004.041889
25. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. EL Knight JC Verhave D Spiegelman HL Hillege D de Zeeuw GC Curhan PE de Jong, Kidney Int 2004 65 4 1416 1421 15086483 10.1111/j.1523-1755.2004.00517.x
26. Tissue distribution and clearance of soluble murine TNF receptors in mice. MH Bemelmans DJ Gouma WA Buurman, Cytokine 1994 6 6 608 615 7893969 10.1016/1043-4666(94)90048-5
27. Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat. JV Castell T Geiger V Gross T Andus E Walter T Hirano T Kishimoto PC Heinrich, Eur J Biochem 1988 177 2 357 361 3263918 10.1111/j.1432-1033.1988.tb14384.x
28. The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo. WL Hutchinson GE Noble PN Hawkins MB Pepys, J Clin Invest 1994 94 4 1390 1396 7929814 10.1172/JCI117474
29. Variability of serum soluble intercellular adhesion molecule-1 measurements attributable to a common polymorphism. TC Register KP Burdon L Lenchik DW Bowden GA Hawkins BJ Nicklas K Lohman FC Hsu CD Langefeld JJ Carr, Clin Chem 2004 50 11 2185 2187 15502096 10.1373/clinchem.2004.036806
30. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). MA Albert RJ Glynn J Buring PM Ridker, Am J Cardiol 2004 93 10 1238 1242 15135696 10.1016/j.amjcard.2004.01. 067
31. Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. L Fried C Solomon M Shlipak S Seliger C Stehman-Breen AJ Bleyer P Chaves C Furberg L Kuller A Newman, J Am Soc Nephrol 2004 15 12 3184 3191 15579522 10.1097/01.ASN.0000146422.45434.35
32. Inflammation, obesity and cardiovascular function in African and Caucasian women from South Africa: the POWIRS study. AE Schutte D van Vuuren JM van Rooyen HW Huisman R Schutte L Malan NT Malan, J Hum Hypertens 2006 20 11 850 859 16855625 10.1038/sj.jhh.1002065
33. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. YC Ma L Zuo JH Chen Q Luo XQ Yu Y Li JS Xu SM Huang LN Wang W Huang, J Am Soc Nephrol 2006 17 10 2937 2944 16988059 10.1681/ASN.2006040368